Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06699797Not ApplicableActive Not Recruiting

Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant

Role: lead

NCT02689349Not ApplicableCompleted

Esteem New Subject Enrollment Post Approval Study

Role: lead

NCT01092910Not ApplicableCompleted

Esteem Totally Implantable Hearing System

Role: lead

NCT02666222Completed

The Esteem® Hearing Implant Post Approval Study

Role: lead

All 4 trials loaded